ConductScience.org, home

Trial · NCT01190813

Registered outcomes43

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDistribution of Amblyopic Eye Visual Acuity Change From Baseline18 weeks after enrollment
The primary outcome is the amblyopic eye visual acuity letter score measured at the 18-week primary outcome visit following a rapid taper of study medicine beginning at week 16. The primary analytic approach will be a treatment group comparison of the mean amblyopic eye visual acuity adjusted for baseline acuity. Visual acuity was measured in each eye (right eye first) by a study-certified VA tester using the Electronic Early Treatment of Diabetic Retinopathy Study (E-ETDRS©) visual acuity protocol. Five letters is equivalent to one logMAR line.
PrimaryMean Amblyopic Eye Visual Acuity Change From Baseline18 weeks after enrollment
The primary outcome is the amblyopic eye visual acuity letter score measured at the 18-week primary outcome visit following a rapid taper of study medicine beginning at week 16. The primary analytic approach will be a treatment group comparison of the mean amblyopic eye visual acuity adjusted for baseline acuity. Visual acuity was measured in each eye (right eye first) by a study-certified VA tester using the Electronic Early Treatment of Diabetic Retinopathy Study (E-ETDRS©) visual acuity protocol. Five letters is equivalent to one logMAR line.
SecondaryAmblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 18 Weeks18 weeks after enrollmentTreatment group comparisons of the proportion of subjects who have improved from baseline by 10 or more letters.
SecondaryDistribution of Amblyopic Eye Visual Acuity at 18 Weeks18 weeks after enrollment
SecondaryMean Amblyopic Eye Visual Acuity at 18 Weeks18 weeks after enrollment
Visual acuity was measured in each eye (right eye first) by a study-certified VA tester using the Electronic Early Treatment of Diabetic Retinopathy Study (E-ETDRS©) visual acuity protocol. Five letters is equivalent to one logMAR line.
SecondaryAmblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 4 Weeks4 weeks after enrollmentTreatment group comparisons adjusted for baseline acuity scores using logistic regression of the proportion of subjects who have improved from baseline by 10 or more letters.
SecondaryAmblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 10 Weeks10 weeks after enrollmentTreatment group comparisons of the proportion of subjects who have improved from baseline by 10 or more letters.
SecondaryAmblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 16 Weeks16 weeks after enrollmentTreatment group comparisons of the proportion of subjects who have improved from baseline by 10 or more letters.
SecondaryAmblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 26 Weeks26 weeks after enrollmentTreatment group comparisons adjusted for baseline acuity scores using logistic regression of the proportion of subjects who have improved from baseline by 10 or more letters.
SecondaryAmblyopia Resolutionat 4 Weeks4 weeks after enrollmentTreatment group comparisons adjusted for baseline acuity scores using logistic regression of the proportion of subjects with 20/25 or better visual acuity.
SecondaryAmblyopia Resolution at 10 Weeks10 weeks after enrollmentTreatment group comparisons adjusted for baseline acuity scores using logistic regression of the proportion of subjects with 20/25 or better visual acuity.
SecondaryAmblyopia Resolution at 16 Weeks16 weeks after enrollmentTreatment group comparisons adjusted for baseline acuity scores using logistic regression of the proportion of subjects with 20/25 or better visual acuity.
SecondaryAmblyopia Resolution at 18 Weeks18 weeks after enrollmentTreatment group comparisons adjusted for baseline acuity scores using logistic regression of the proportion of subjects with 20/25 or better visual acuity.
SecondaryAmblyopia Resolution at 26 Weeks26 weeks after enrollmentTreatment group comparisons adjusted for baseline acuity scores using logistic regression of the proportion of subjects with 20/25 or better visual acuity.
SecondaryDistribution of Amblyopic Eye Visual Acuity Change From Baseline at 4 Weeks4 weeks after enrollment
Visual acuity was measured in each eye (right eye first) by a study-certified VA tester using the Electronic Early Treatment of Diabetic Retinopathy Study (E-ETDRS©) visual acuity protocol. Five letters is equivalent to one logMAR line.
SecondaryMean Change in Amblyopic Eye Visual Acuity From Baseline at 4 Weeks4 weeks after enrollmentA treatment group comparison of the mean amblyopic eye visual acuity at 4 weeks after enrollment, adjusted for baseline acuity.
SecondaryDistribution of Amblyopic Eye Visual Acuity Change From Baseline at 10 Weeks10 weeks after enrollment
Visual acuity was measured in each eye (right eye first) by a study-certified VA tester using the Electronic Early Treatment of Diabetic Retinopathy Study (E-ETDRS©) visual acuity protocol. Five letters is equivalent to one logMAR line.
SecondaryMean Change in Amblyopic Eye Visual Acuity From Baseline at 10 Weeks10 weeks after enrollment
A treatment group comparison of the mean amblyopic eye visual acuity at 10 weeks after enrollment, adjusted for baseline acuity. Visual acuity was measured in each eye (right eye first) by a study-certified VA tester using the Electronic Early Treatment of Diabetic Retinopathy Study (E-ETDRS©) visual acuity protocol. Five letters is equivalent to one logMAR line.
SecondaryDistribution of Amblyopic Eye Visual Acuity Change From Baseline at 16 Weeks16 weeks after enrollment
Visual acuity was measured in each eye (right eye first) by a study-certified VA tester using the Electronic Early Treatment of Diabetic Retinopathy Study (E-ETDRS©) visual acuity protocol. Five letters is equivalent to one logMAR line.
SecondaryMean Change in Amblyopic Eye Visual Acuity From Baseline at 16 Weeks16 weeks after enrollment
A treatment group comparison of the mean amblyopic eye visual acuity at 16 weeks after enrollment, adjusted for baseline acuity. Visual acuity was measured in each eye (right eye first) by a study-certified VA tester using the Electronic Early Treatment of Diabetic Retinopathy Study (E-ETDRS©) visual acuity protocol. Five letters is equivalent to one logMAR line.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01190813/registered